DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,752,852 | +1.8% | 19,157 | -1.5% | 0.55% | -8.0% |
| Q2 2023 | $4,666,560 | -5.7% | 19,444 | -0.9% | 0.60% | -12.3% |
| Q1 2023 | $4,946,537 | +94806.7% | 19,626 | -0.1% | 0.68% | -11.2% |
| Q4 2022 | $5,212 | -99.9% | 19,638 | +0.1% | 0.77% | +3.1% |
| Q3 2022 | $5,070,000 | +0.2% | 19,628 | -1.7% | 0.75% | -9.2% |
| Q2 2022 | $5,061,000 | -13.7% | 19,962 | -0.2% | 0.82% | -1.6% |
| Q1 2022 | $5,865,000 | -12.0% | 19,993 | -1.3% | 0.84% | -8.7% |
| Q4 2021 | $6,665,000 | +7.3% | 20,258 | -0.7% | 0.92% | -2.4% |
| Q3 2021 | $6,214,000 | +7.7% | 20,410 | -5.1% | 0.94% | +7.3% |
| Q2 2021 | $5,771,000 | +35.3% | 21,505 | +13.5% | 0.88% | +26.4% |
| Q1 2021 | $4,266,000 | -1.3% | 18,955 | -2.6% | 0.69% | -8.5% |
| Q4 2020 | $4,324,000 | +3.1% | 19,465 | -0.1% | 0.76% | -7.9% |
| Q3 2020 | $4,196,000 | +17.6% | 19,485 | -3.5% | 0.82% | +8.9% |
| Q2 2020 | $3,569,000 | +120.7% | 20,185 | +72.8% | 0.75% | +58.4% |
| Q1 2020 | $1,617,000 | -11.3% | 11,682 | -1.6% | 0.48% | +10.7% |
| Q4 2019 | $1,822,000 | +5.4% | 11,872 | -0.8% | 0.43% | -1.4% |
| Q3 2019 | $1,729,000 | +1.2% | 11,972 | +0.1% | 0.44% | -1.4% |
| Q2 2019 | $1,709,000 | +7.3% | 11,957 | -0.8% | 0.44% | +3.3% |
| Q1 2019 | $1,592,000 | +30.7% | 12,057 | +2.0% | 0.43% | +13.2% |
| Q4 2018 | $1,218,000 | -5.6% | 11,819 | -0.4% | 0.38% | +8.9% |
| Q3 2018 | $1,290,000 | +121.3% | 11,869 | +101.1% | 0.35% | +106.5% |
| Q2 2018 | $583,000 | -0.5% | 5,903 | -1.3% | 0.17% | -5.1% |
| Q1 2018 | $586,000 | -4.9% | 5,978 | -9.9% | 0.18% | -2.2% |
| Q4 2017 | $616,000 | +3.2% | 6,638 | -4.7% | 0.18% | -3.2% |
| Q3 2017 | $597,000 | -5.2% | 6,963 | -6.7% | 0.19% | -8.3% |
| Q2 2017 | $630,000 | -5.8% | 7,463 | -4.6% | 0.20% | -10.1% |
| Q1 2017 | $669,000 | -4.7% | 7,823 | -13.3% | 0.23% | -8.1% |
| Q4 2016 | $702,000 | -20.3% | 9,023 | -19.6% | 0.25% | -22.3% |
| Q3 2016 | $881,000 | -53.6% | 11,228 | -40.3% | 0.32% | -54.5% |
| Q2 2016 | $1,899,000 | +6.5% | 18,803 | 0.0% | 0.70% | +6.2% |
| Q1 2016 | $1,783,000 | +20.6% | 18,803 | +18.2% | 0.66% | +17.7% |
| Q4 2015 | $1,478,000 | +139.2% | 15,913 | +119.4% | 0.56% | +129.1% |
| Q3 2015 | $618,000 | +153.3% | 7,254 | +154.2% | 0.24% | +171.1% |
| Q2 2015 | $244,000 | +0.8% | 2,854 | 0.0% | 0.09% | 0.0% |
| Q1 2015 | $242,000 | -0.8% | 2,854 | 0.0% | 0.09% | -6.2% |
| Q4 2014 | $244,000 | +12.4% | 2,854 | 0.0% | 0.10% | +7.9% |
| Q3 2014 | $217,000 | – | 2,854 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |